112 related articles for article (PubMed ID: 8083806)
1. Disposition of nifurtimox and metabolite activity against Trypanosoma cruzi using rat isolated perfused liver.
González-Martin G; Paulos C; Guevara A; Ponce G
J Pharm Pharmacol; 1994 May; 46(5):356-9. PubMed ID: 8083806
[TBL] [Abstract][Full Text] [Related]
2. The disposition of nifurtimox in the rat isolated perfused liver: effect of dose size.
González-Martin G; Ponce G; Inostroza V; González M; Paulos C; Guevara A
J Pharm Pharmacol; 1993 Jan; 45(1):72-4. PubMed ID: 8094453
[TBL] [Abstract][Full Text] [Related]
3. Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver.
Booth CL; Brouwer KR; Brouwer KL
Cancer Res; 1998 Aug; 58(16):3641-8. PubMed ID: 9721873
[TBL] [Abstract][Full Text] [Related]
4. Disposition of the antimalarial, mefloquine, in the isolated perfused rat liver.
Coleman MD; Fleckenstein L; Shipley LA; Heiffer MH
Biochem Pharmacol; 1988 Jan; 37(2):235-9. PubMed ID: 3257698
[TBL] [Abstract][Full Text] [Related]
5. Disposition of amphotericin B in the isolated perfused rat liver.
Hong Y; Ramzan I; McLachlan AJ
J Pharm Pharmacol; 2004 Jan; 56(1):35-41. PubMed ID: 14979999
[TBL] [Abstract][Full Text] [Related]
6. Enantiomers of nifurtimox do not exhibit stereoselective anti-Trypanosoma cruzi activity, toxicity, or pharmacokinetic properties.
Moraes CB; White KL; Braillard S; Perez C; Goo J; Gaspar L; Shackleford DM; Cordeiro-da-Silva A; Thompson RC; Freitas-Junior L; Charman SA; Chatelain E
Antimicrob Agents Chemother; 2015; 59(6):3645-7. PubMed ID: 25845874
[TBL] [Abstract][Full Text] [Related]
7. Hepatobiliary disposition of rhodamine 123 in isolated perfused rat livers.
Parasrampuria R; Mehvar R
Xenobiotica; 2008 Oct; 38(10):1263-73. PubMed ID: 18798123
[TBL] [Abstract][Full Text] [Related]
8. The disposition of an antileishmanial 8-aminoquinoline drug in the isolated perfused rat liver: thermospray liquid chromatography-mass spectrometry identification of metabolites.
Shipley LA; Coleman MD; Brewer TG; Ashmore RW; Theoharides AD
Xenobiotica; 1990 Jan; 20(1):31-44. PubMed ID: 2327106
[TBL] [Abstract][Full Text] [Related]
9. The disposition of morphine and its metabolites in the in-situ rat isolated perfused liver.
Evans AM; Shanahan K
J Pharm Pharmacol; 1995 Apr; 47(4):333-9. PubMed ID: 7791033
[TBL] [Abstract][Full Text] [Related]
10. Nitrofurazone disposition by perfused rat liver. Effect of dose size and glutathione depletion.
Sorrentino D; Bode W; Hoener BA
Biochem Pharmacol; 1987 Mar; 36(6):915-8. PubMed ID: 3566788
[TBL] [Abstract][Full Text] [Related]
11. Uptake and excretion of vecuronium bromide and pancuronium bromide in the isolated perfused rat liver.
Bencini AF; Mol WE; Scaf AH; Kersten UW; Wolters KT; Agoston S; Meijer DK
Anesthesiology; 1988 Oct; 69(4):487-92. PubMed ID: 2902816
[TBL] [Abstract][Full Text] [Related]
12. The disposition of quinine in the rat isolated perfused liver: effect of dose size.
Coleman MD; Timony G; Fleckenstein L
J Pharm Pharmacol; 1990 Jan; 42(1):26-9. PubMed ID: 1969945
[TBL] [Abstract][Full Text] [Related]
13. The metabolism of d-, l- and dl-methadone in the isolated perfused rat liver.
Gerber N; Leger RM; Gordon P; Smith RG; Bauer J; Lynn RK
J Pharmacol Exp Ther; 1977 Mar; 200(3):487-95. PubMed ID: 850125
[TBL] [Abstract][Full Text] [Related]
14. Trypanosoma cruzi: In vitro effect of aspirin with nifurtimox and benznidazole.
López-Muñoz R; Faúndez M; Klein S; Escanilla S; Torres G; Lee-Liu D; Ferreira J; Kemmerling U; Orellana M; Morello A; Ferreira A; Maya JD
Exp Parasitol; 2010 Feb; 124(2):167-71. PubMed ID: 19735656
[TBL] [Abstract][Full Text] [Related]
15. Lipid alterations induced by nifurtimox in Trypanosoma cruzi.
Barreto-Bergter E; Hogge L; Steele da Cruz F
Mol Biochem Parasitol; 1986 Dec; 21(3):221-6. PubMed ID: 3543670
[TBL] [Abstract][Full Text] [Related]
16. Characterization and trypanocidal activity of nifurtimox-containing and empty nanoparticles of polyethylcyanoacrylates.
Gonzalez-Martin G; Merino I; Rodriguez-Cabezas MN; Torres M; Nuñez R; Osuna A
J Pharm Pharmacol; 1998 Jan; 50(1):29-35. PubMed ID: 9580223
[TBL] [Abstract][Full Text] [Related]
17. The disposition of primaquine in the isolated perfused rat liver. Stereoselective formation of the carboxylic acid metabolite.
Nicholl DD; Edwards G; Ward SA; Orme ML; Breckenridge AM
Biochem Pharmacol; 1987 Oct; 36(20):3365-9. PubMed ID: 3675598
[TBL] [Abstract][Full Text] [Related]
18. The disposition of suramin in the isolated perfused rat liver.
Coleman MD; Adjepon-Yamoah KK
Biochem Pharmacol; 1986 Oct; 35(19):3389-92. PubMed ID: 3768027
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of 14C-2',3'-dideoxyinosine by the in situ perfused rat liver preparation.
Tay LK; Papp EA; Timoszyk J
Biopharm Drug Dispos; 1991 May; 12(4):285-97. PubMed ID: 1908338
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of paclitaxel elimination in the isolated perfused rat liver by Cremophor EL.
Ellis AG; Webster LK
Cancer Chemother Pharmacol; 1999; 43(1):13-8. PubMed ID: 9923536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
